Livmarli (maralixibat) / Takeda, CANbridge Pharma, Mirum Pharma  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Livmarli (maralixibat) / Mirum Pharma
NCT02475317: Study to Assess the Relative Potency of Multiple Oral Doses of LUM001 and SHP626 in Overweight and Obese Adults as Assessed by Fecal Bile Acid Excretion

Completed
1
84
US
Placebo, Maralixibat, LUM001, Volixibat, SHP626
Mirum Pharmaceuticals, Inc.
Healthy Volunteers
12/15
12/15

Download Options